Cargando…

PD-L1 Expression and CD8(+) T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer

Advanced gastric cancer (AGC) has high morbidity and mortality in East Asia, and it is urgent to explore new treatments to improve patient prognosis. Programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors have exhibited remarkable activity in clinical trials and were approved by the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yangyang, Zhu, Chunchao, Song, Wei, Li, Jun, Zhao, Gang, Cao, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996418/ https://www.ncbi.nlm.nih.gov/pubmed/30003113 http://dx.doi.org/10.1155/2018/4180517

Ejemplares similares

PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer
por: Wu, Yanhua, et al.
Publicado: (2017)

High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer
por: Hong, Soon Auck, et al.
Publicado: (2020)

Early Increase in Circulating PD-1(+)CD8(+) T Cells Predicts Favorable Survival in Patients with Advanced Gastric Cancer Receiving Chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2023)

Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients
por: Deng, Min, et al.
Publicado: (2021)

Down-Regulated CLDN10 Predicts Favorable Prognosis and Correlates With Immune Infiltration in Gastric Cancer
por: Rao, XiongHui, et al.
Publicado: (2021)

Tumor PD-L1 status and CD8(+) tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer
por: De Meulenaere, Astrid, et al.
Publicado: (2017)

High CD8/CD33 ratio in peritoneal metastatic lesions is associated with favorable prognosis in gastric cancer
por: Yamaguchi, Takahisa, et al.
Publicado: (2021)

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
por: Martin de la Fuente, Laura, et al.
Publicado: (2020)

The Predictive Value of CD3+/CD8+ Lymphocyte Infiltration and PD-L1 Expression in Colorectal Cancer
por: Liu, Jihong, et al.
Publicado: (2023)

CD8(+)PD-1(+) to CD4(+)PD-1(+) ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers
por: Duchemann, Boris, et al.
Publicado: (2022)

PD‐L1+ dendritic cells in the tumor microenvironment correlate with good prognosis and CD8+ T cell infiltration in colon cancer
por: Miller, Timothy J., et al.
Publicado: (2021)

Circulating memory PD-1(+)CD8(+) T cells and PD-1(+)CD8(+)T/PD-1(+)CD4(+)T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
por: Liu, Jiang, et al.
Publicado: (2023)

PD-L1 expression indicates favorable prognosis for advanced lung adenocarcinoma patients treated with pemetrexed
por: Zhang, Pei, et al.
Publicado: (2017)

Low CD8(+) T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44(+)/CD133(+) Cancer Stem Cells and Predict an Unfavorable Prognosis in Pancreatic Cancer
por: Hou, Ya-Chin, et al.
Publicado: (2019)

Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer
por: Zurlo, Ina Valeria, et al.
Publicado: (2021)

Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis
por: Däster, Silvio, et al.
Publicado: (2020)

VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC
por: Zhang, Mi, et al.
Publicado: (2022)

CD103(+) tumor-infiltrating lymphocytes predict favorable prognosis in patients with esophageal squamous cell carcinoma
por: Chu, Yifan, et al.
Publicado: (2019)

PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer
por: Shen, Yang, et al.
Publicado: (2020)

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
por: Schmidt, Lars Henning, et al.
Publicado: (2015)

The combination of NDUFS1 with CD4(+) T cell infiltration predicts favorable prognosis in kidney renal clear cell carcinoma
por: Wu, Dong, et al.
Publicado: (2023)

Sema3C promotes hepatic metastasis and predicts poor prognosis in gastric adenocarcinoma
por: Li, Maoran, et al.
Publicado: (2021)

CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment
por: Zhu, Ying, et al.
Publicado: (2020)

PD-L1 expression combined with microsatellite instability/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer
por: Morihiro, Toshiaki, et al.
Publicado: (2019)

CD8(+ )lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
por: Liu, Shuzhen, et al.
Publicado: (2012)

Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors
por: Wang, Haiyue, et al.
Publicado: (2018)

VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer
por: Jlassi, Aida, et al.
Publicado: (2023)

PD-L1 and tumor-infiltrating CD8(+) lymphocytes are correlated with clinical characteristics in pediatric and adolescent pituitary adenomas
por: Shi, Mengwu, et al.
Publicado: (2023)

PD-1(+)CD8(+) T Cells Proximal to PD-L1(+)CD68(+) Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients
por: Yang, Xiaobao, et al.
Publicado: (2023)

An integrated biomarker of PD‐L1 expression and intraepithelial CD8 (+) T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases
por: Li, Lin‐Lin, et al.
Publicado: (2022)

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC
por: Yang, Zhenlin, et al.
Publicado: (2021)

PD-L1, Galectin-9 and CD8(+) tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
por: Sideras, Kostandinos, et al.
Publicado: (2017)

Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance
por: Xin, Haisong, et al.
Publicado: (2023)

Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival
por: Liu, Jingwei, et al.
Publicado: (2020)

Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer
por: Lu, Jun, et al.
Publicado: (2019)

Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer
por: Chen, Fangfang, et al.
Publicado: (2019)

High expression of CD8 predicts favorable prognosis in patients with lung adenocarcinoma: A cohort study
por: Ye, Sheng-Lan, et al.
Publicado: (2017)

Tumor-infiltrating macrophages express interleukin-25 and predict a favorable prognosis in patients with gastric cancer after radical resection
por: Li, Jinqing, et al.
Publicado: (2016)

The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy
por: Jin, Shenying, et al.
Publicado: (2017)

Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma
por: Zhang, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b2pmj38h0mkbvmbetgio2kv9hm